Sheila MacLennan

2.7k total citations
22 papers, 773 citations indexed

About

Sheila MacLennan is a scholar working on Management of Technology and Innovation, Hematology and Epidemiology. According to data from OpenAlex, Sheila MacLennan has authored 22 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Management of Technology and Innovation, 6 papers in Hematology and 5 papers in Epidemiology. Recurrent topics in Sheila MacLennan's work include Blood donation and transfusion practices (7 papers), Blood groups and transfusion (5 papers) and Blood transfusion and management (4 papers). Sheila MacLennan is often cited by papers focused on Blood donation and transfusion practices (7 papers), Blood groups and transfusion (5 papers) and Blood transfusion and management (4 papers). Sheila MacLennan collaborates with scholars based in United Kingdom, Nigeria and United States. Sheila MacLennan's co-authors include D. Stainsby, Dafydd G. Thomas, P. J. Hamilton, Patrick Hamilton, John A.J. Barbara, Patricia E. Hewitt, J. A. J. Barbara, Geoff Daniels, Nicole H. Smith and Joyce Poole and has published in prestigious journals such as British Journal of Haematology, British Journal of Anaesthesia and British Journal of Ophthalmology.

In The Last Decade

Sheila MacLennan

22 papers receiving 719 citations

Peers

Countries citing papers authored by Sheila MacLennan

Since Specialization

Citations

This map shows the geographic impact of Sheila MacLennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila MacLennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila MacLennan more than expected).

Fields of papers citing papers by Sheila MacLennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila MacLennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila MacLennan. The network helps show where Sheila MacLennan may publish in the future.

Co-authorship network of co-authors of Sheila MacLennan

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila MacLennan. A scholar is included among the top collaborators of Sheila MacLennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila MacLennan. Sheila MacLennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EVOLVE: Designing a model of meaningful patient involvement in guideline development 2019 ·European Urology Supplements ·(unknown), Sheila MacLennan, Rachel Giles, Philip Cornford, Steven MacLennan	1
2	Selection strategies for newly registered blood donors in European countries. 2017 ·PubMed ·(unknown), Dragoslav Domanović, Wim de Kort, Wolfgang R. Mayr, Giancarlo M Liumbruno, Simonetta Pupella, (unknown), Folke Knutson, Sheila MacLennan, Gilles Folléa	14
3	A European survey on donor deferral for allergy: Rationale and initial results of a survey in 35 countries 2017 ·Transfusion Clinique et Biologique ·Olivier Garraud, (unknown), Antoine Haddad, (unknown), G Rautmann, Sheila MacLennan, Rut Norda	1
4	Focus on fresh frozen plasma – facilitating optimal management of bleeding through collaboration between clinicians and transfusion specialists on component specifications 2016 ·La Presse Médicale ·Sheila MacLennan	3
5	Pathogen‐reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola‐specific neutralizing antibodies 2016 ·Vox Sanguinis ·Christof Geisen, Gerrit Kann, Thomas Strecker, Timo Wolf, Gundolf Schüttfort, Marian van Kraaij, Sheila MacLennan, Silke Rummler, Christina Weinigel, Markus Eickmann, Sarah K. Fehling, Verena Krähling, Christian Seidl, Erhard Seifried, Michael Schmidt, Richard Schäfer	11
6	A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2‐ to 5‐ versus 6‐ or 7‐day–stored platelets 2015 ·Transfusion ·Sheila MacLennan, (unknown), Charlotte Llewelyn, Louise Choo, (unknown), Edwin Massey, Simon Stanworth, K. Pendry, Lorna M. Williamson	28
7	Strategies for screening blood donors to source convalescent H1N1v plasma for intervention therapy 2012 ·Vox Sanguinis ·R.P. Parry, Kate I. Tettmar, Katja Höschler, Susan R. Brailsford, Dhanraj Samuel, Marianne Ashford, Sheila MacLennan, L. M. Williamson, Richard S. Tedder	7
8	Allogeneic blood components 2008 ·Transfusion Alternatives in Transfusion Medicine ·Rebecca Cardigan, Sheila MacLennan	3
9	Risks and side effects of therapy with plasma and plasma fractions 2006 ·Best Practice & Research Clinical Haematology ·Sheila MacLennan, John A.J. Barbara	67
10	Guidelines on the management of massive blood loss 2006 ·British Journal of Haematology ·D. Stainsby, Sheila MacLennan, Dafydd G. Thomas, (unknown), P. J. Hamilton	276
11	Reference intervals for plasma proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK 2004 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·A. Myron Johnson, Per Hyltoft Petersen, J T Whicher, Anders Carlström, Sheila MacLennan	23
12	The clinical significance of blood group antibodies 2002 ·Transfusion Medicine ·Geoff Daniels, Joyce Poole, (unknown), (unknown), Sheila MacLennan, Nicole H. Smith	66
13	Survey of the use of whole blood in current blood transfusion practice 2001 ·Clinical & Laboratory Haematology ·Sheila MacLennan, Michael Murphy	18
14	The low‐incidence MNS antigens M^v, s^D, and Mit arise from single amino acid substitutions on GPB 2001 ·Transfusion ·Jill R. Storry, Marion E. Reid, Sheila MacLennan, A. Lubenko, (unknown)	12
15	Management of massive blood loss: a template guideline 2000 ·British Journal of Anaesthesia ·D. Stainsby, Sheila MacLennan, Patrick Hamilton	147
16	Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests 2000 ·Hematological Oncology ·Faith E. Davies, Andy C. Rawstron, Guy Pratt, (unknown), Deborah Clarke, A. Lubenko, (unknown), Timothy Perren, Peter J. Selby, Sheila MacLennan, (unknown), (unknown), (unknown), J. A. Child, Graeme Smith, Peter Johnson, Gareth J. Morgan	3
17	Prophylaxis with anti-D immunoglobulin 1994 ·BMJ ·Sheila MacLennan, Peter Flanagan	3
18	Follow up of blood donors positive for antibodies to hepatitis C virus 1994 ·BMJ ·Kathleen E. Ryan, Sheila MacLennan, J. A. J. Barbara, Patricia E. Hewitt	21
19	A study of anti‐hepatitis C positive blood donors: the first year of screening 1994 ·Transfusion Medicine ·Sheila MacLennan, (unknown), Patricia E. Hewitt, (unknown), J. A. J. Barbara	36
20	Cataract surgery: interim results and complications of a randomised controlled trial. Oxford Cataract Treatment and Evaluation Team (OCTET). 1986 ·British Journal of Ophthalmology ·(unknown), Anthony J. Bron, H Cheng, D L Boase, (unknown), Richard Fordham, (unknown), P Jacobs, M Noble, Sheila MacLennan, A K Bates, (unknown), Rubén Medina, J I Mann, (unknown), Douglas W. White, (unknown), M.E. Platts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact